In the first episode of this three-part miniseries, Is IPLEDGE Working? A Conversation on Risk Management and Isotretinoin, Dr. Leah Lalor talks about the program’s history with Dr. Jill Lindstrom. Listen as Dr. Lindstorm shares important information on the evolution of this REMS (Risk Evaluation and Mitigation Strategy) program for isotretinoin and how the program was molded into what it is today. Dr. Lindstrom is a practicing dermatologist at Walter Reed National Military Medical Center. She was previously the Deputy Director of the Division of Dermatology and Dental Products at FDA, where she worked for 17 years.